Background: In this study, the prognostic impact of the presence of the multifocal or multicentric tumor (MMT) and its association with molecular subtypes were investigated.
introduction
The diameter of the invasive carcinoma is a well-known risk factor of recurrence and death in breast cancer patients, and constitutes an integral part of the TNM staging [1, 2] . Although recent advances in cancer research have opened the era of molecular characterization of the individual tumors, the microscopic tumor size is still a major factor influencing the choice of adjuvant therapies in breast cancer patients [3] . When the patient has multiple invasive tumors in the same breast (multifocal or multicentric tumors, MMTs), the current TNM system uses the diameter of the largest invasive tumor for T staging. The reasons for this 'largest diameter only' principle would be the practicality and convenience as well as the assumption that most clinically relevant cancer cell disseminations originate from the dominant (largest) invasive foci.
Several studies have reported the association between the multifocal or multicentric nature of breast cancer and the incidence of axillary lymph node metastasis [4] [5] [6] [7] [8] [9] , and some investigators have proposed different size measurement techniques to calibrate the risk of nodal involvement [4, 6, 10, 11] . However, the clinical implications of these novel measurement techniques are limited since the degree of nodal involvement is already integrated in the current TNM staging system. Therefore, to address the prognostic significance of MMT, the association between the presence of MMT and the occurrence of metastasis or death should be investigated.
In this study, we aimed to determine the association between the multifocality or multicentricity of breast cancer and treatment outcomes by using both institutional breast cancer database and nationwide breast cancer registry data in Korea. We specifically analyzed the data according to the breast cancer molecular subtypes, since recent studies have suggested that the cancer cell's ability to disseminate may vary according to the molecular subtypes of breast cancer at a given size of the primary tumor [12] [13] [14] .
patients and methods
This study was approved by the Institutional Review Board of Seoul National University Hospital (IRB No: H-1210-071-434) and conducted in accordance with Helsinki declaration.
Seoul National University Hospital Breast Care Center (SNUHBCC) database
The SNUHBCC database is a prospectively maintained, web-based system that includes information on all patients who have undergone operations for breast diseases at the Seoul National University Hospital since 1982 [15] . This database provides detailed information on the type of breast tumor and the date of breast cancer recurrence.
From the database, a total of 2882 patients were identified based on the following conditions; (i) patients with invasive carcinoma, (ii) patients who were treated between January 2000 and July 2007, (iii) excluding patients with T4 tumors or distant metastasis and (iv) patients with available ER, PR, HER2 expression data. The tumors were defined as multifocal or MMTs when invasive cancers are separated by normal breast tissue of >5 mm [16] .
Korean Breast Cancer Registry
Korean Breast Cancer Registry (KBCR) is a prospectively maintained, multiinstitutional registry of the Korean Breast Cancer Society. The structure and the detailed information of the KBCR registry have been previously reported [15] . Nationwide, breast surgeons in 102 teaching hospitals participate in this program. As of 2004, this registry was estimated to include >50% of all newly diagnosed breast cancer patients in Korea. Essential items include each patient's unique Korean resident's registration number as an identifier, sex, age, surgical method and cancer stage based on the American Joint Committee on Cancer classification. The number of invasive foci is an optional item. MMTs were defined as the tumor with more than two invasive foci. Between January 1995 and July 2007, 41 179 patients with available information on the number of invasive foci were identified from the database.
For KBCR, the detailed information on the types of recurrence is not available. The information on the date and the cause of death was obtained from the Korean Central Cancer Registry, Ministry of Health and Welfare, Korea [17] .
statistical analysis
Molecular subtypes of breast cancer were classified into luminal A, luminal B, HER2 and triple-negative subtypes according to the ER PR, and HER2 expression status [18] . For SNUHBCC dataset, the ER and PR positivity were defined by the cut-off of 10% and HER2-positive tumors were either strong positive on immunochemical staining or gene amplification on FISH. For KBCR dataset, ER, PR and HER2 status were defined based on each institution's report. Characteristics of each group were compared by using the χ 2 test and Student's t-test. Univariate survival analysis was carried out using the Kaplan-Meier method, and log-rank tests were employed for comparison of survival curves. Multivariate analyses were conducted using Cox's proportional hazard regression model. To identify independent factors which predict the lymph node metastasis, logistic regression analysis was used.
Overall survival was defined as the time from surgery of primary breast cancer to death from any cause, and distant metastasis-free survival was defined as the time from surgery to developing any recurrence at a distant site, including contralateral axillary and supraclavicular lymph nodes. All statistical analyses were carried out using SPSS version 12.0 (SPSS, Chicago, IL).
results

patients' characteristics and the incidence of MMT
The characteristics of the studied patients are listed in the supplementary Table S1 , available at Annals of Oncology online. Both SNUHBCC and KBCR datasets showed high similarity in terms of clinical characteristics of the studied patients. There were 281 (9.8%) and 4469 (10.9%) patients with MMTs in SNUHBCC and KBCR datasets, respectively. Table 1 shows the results of the comparison between patients with single breast carcinoma and patients with MMTs. Patients with MMTs had higher incidence of axillary nodal metastasis when compared with that of patients with single-invasive carcinoma and received mastectomy more often.
distant metastasis in patients with MMTs in SNUHBCC dataset
SNUHBCC database provides detailed information on the tumor characteristics and the date and type of the recurrence. We evaluated the prognostic significance of a MMT in the 2882 patients from the SNUHBCC database. Overall, patients with MMT had similar metastasis-free survival when compared with the patients with single-invasive carcinoma regardless of the nodal status ( Figure 1A and B). Interestingly, a significant difference in metastasis-free survival was observed only in patients with ER-negative tumors (supplementary Figure S1 , available at Annals of Oncology online). To further analyze the association between multiplicity or multicentricity and incidence of distant metastasis, tumors were classified according to the molecular subtypes. The prognostic significance of a MMT in terms of metastasis-free survival was only seen in patients with triple-negative tumors ( Figure 1C -F), suggesting that additional invasive foci may contribute to the development of distant metastasis in triple-negative breast cancer patients. The Cox proportional hazard model further showed the independent prognostic role of MMT in triple-negative breast cancer patients in predicting distant metastasis (Table 2) .
overall survival in patients with MMT in SNUHBCC and KBCR datasets
The KBCR dataset which included 41 179 breast cancer patients was analyzed to validate the prognostic significance of MMT. Consistent with the results from the SNUHBCC dataset, the difference in overall survival according to the presence of MMT was significant only in patients with triple-negative breast cancers ( Figure 2 ). The Cox proportional hazard model, adjusted for other prognostic factors, has again showed the independent role of MMT in predicting overall survival only in triple-negative breast cancer patients ( Table 2 ). The presence of MMT was associated with 32% increased risk of death in patients with triple-negative breast cancer. The prognostic significance of MMT was also seen when administration of various adjuvant treatments was included in the Cox regression models (supplementary Table S2 , available at Annals of Oncology online).
The SNUHBCC dataset does not fully provide the overall survival data since most patients are referred to nearby institution for care during their course of palliative treatment. Nevertheless, the effect of having MMT on overall survival in triple-negative breast cancer patients was also observed in the SNUHBCC dataset (supplementary Figure S2 , available at Annals of Oncology online and Table 2 ). lymph node metastasis and death along the tumor size change in different subtypes of breast cancer
To assess the incidence and degree of lymph node metastasis along the tumor size change, we analyzed the association between the nodal status and the primary tumor size in the KBCR dataset. When classified according to the tumor size, triple-negative breast cancer patients showed a unique pattern in terms of the number of metastatic lymph nodes and the proportion of nodal involvement when compared with other subtypes. While other tumors showed a consistent increase in nodal involvement along the tumor size, triple-negative breast cancers showed a plateau pattern in the incidence and degree of nodal metastasis in tumors <2 cm ( Figure 3A and supplementary Figure S3 , available at Annals of Oncology online).
The HR for death along the tumor size change which was adjusted for lymph node status, histologic grade, and age at diagnosis was also investigated to assess the independent role of tumor size change in KBCR dataset. The HR in triple-negative subtype was higher than other subtypes even in small tumors and the association showed a plateau pattern in tumors <2 cm ( Figure 3B ).
discussion
There has been a long controversy on the issue of the proper tumor size measuring for patients with multifocal or multicentric invasive foci in the same breast. The controversy is based on the idea that the chance for the cancer cell to metastasize is proportional to the tumor load (volume or surface area) for all cancer cells rather than the cells in the largest invasive foci [19, 20] . Indeed, numerous studies have reported the increased risk of lymph node involvement in patients with MMTs, suggesting that even the smaller invasive foci can contribute to the lymphatic dissemination [4] [5] [6] [7] [8] [9] . Our results also show that patients with MMTs are at increased risk To understand the independent prognostic role of MMT, many researchers investigated the treatment outcome of patients with MMT. While some earlier studies showed inferior outcomes in patients with MMTs when compared with that of patients with single carcinomas [21, 22] , the following studies reported lack of such association [7-10, 23, 24] . One possible reason for these inconsistent results is that none has investigated Figure 1 . The Kaplan-Meier survival curves for distant metastasis in patients with multifocal or multicentric tumors (MMTs) from the SNUHBCC dataset. The distant metastasis-free survival was evaluated in the all studied patients (A), and according to the nodal status (B) and molecular subtypes (C-F).
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the prognostic role of MMT in the subtype-specific manner. The biology underlying predicting recurrence in breast cancer varies among the molecular subtypes of each tumor [12, 13, 25] , and the importance of molecular subtype is further suggested by the repeated observation of the possible association between the ER expression status and the incidence of MMT in our present data as well as the DBCG data [7] .
In the present study, we have investigated the relationship between the presence of MMT and breast cancer metastasis and death in two relatively large databases of Korean breast cancer patients. By analyzing the data from 2882 patients in the SNUHBCC dataset, we were able to show the significant association between the presence of MMT in triple-negative subtype and distant metastasis as well as death. The finding was reproduced in the KBCR dataset involving 41 179 breast cancer patients by showing a significantly shorter overall survival in patients with MMTs when the tumor was triple-negative subtype. Interestingly, the observed survival difference between patients with MMTs and single invasive tumors was mostly seen during the early period of follow-up, suggesting that the clinical importance of the MMT is mainly in predicting early relapse in triple-negative tumors. Our results provide an important evidence that support a novel subtype-specific approach in predicting the prognostic outcome in patients with MMTs, 
which is clearly different from the current AJCC/TNM staging system that uses the diameter of the dominant invasive lesion regardless of the molecular characteristics of the tumors. It is not clear how the presence of smaller additional malignant foci contribute to worse outcome in triple-negative breast cancers. One possible explanation can be that triplenegative breast cancers acquire the ability to disseminate during the early period of the tumor growth which may result in clinically relevant risk of recurrence. Our results also show that in triple-negative tumors, the incidence of lymphatic dissemination is higher in small tumors and is consistent until the tumors reach the diameter of 2 cm. This hypothesis is supported by the recent clinical studies that show the lack of correlation between the tumor size and nodal metastasis or survival in triple-negative breast cancer patients [26] [27] [28] . Additionally, it has been shown that the risk of visceral metastasis is significant in the triple-negative breast cancer patients even when the tumors are small [29] , and in ERnegative breast cancer patients, the survival is not proportional to the T stage when there is a significant nodal involvement [14] . Our results clearly show that the risk of death is higher in small triple-negative breast cancers when compared with that of ER-positive tumors, and the risk shows a plateau pattern until the tumors reach the size of 2 cm.
Our study carries some important limitations. First, the multifocality is not mandatory information in the KBCR database, and the study design was retrospective in nature, and therefore, the risk of selection bias is present. Second, the definition of multifocal or MMTs may differ among the participating institutions [30] . Finally, the information on the tumor size of the additional invasive foci was not available for aggregate diameter or surface volume measurement for MMT.
In conclusion, our study reports a novel observation that patients with MMTs carry significantly worse outcome when the tumors are triple-negative subtype. This observation provides evidence for a subtype-specific approach in predicting the outcome in patients with MMTs.
